Zeropain SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100mg), Paracetamol (325mg), and Serratiopeptidase (15mg). Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), provides effective relief from pain and inflammation by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol acts as an analgesic and antipyretic, alleviating mild to moderate pain and reducing fever through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and swelling. The synergistic action of these components makes Zeropain SP Tablet suitable for managing various musculoskeletal disorders, postoperative pain, dental pain, and inflammatory conditions such as arthritis and soft tissue injuries. It is generally well-tolerated when used as directed; however, caution is advised in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to NSAIDs or any component of the formulation. The medication should be taken under medical supervision, adhering to prescribed dosages to minimize potential adverse effects such as gastrointestinal discomfort, allergic reactions, or hepatic dysfunction. Zeropain SP Tablet offers a comprehensive approach to pain and inflammation management, improving patient comfort and functional recovery.